WO2001021108A1 - Implants for the use in the treatment of aneurysms - Google Patents
Implants for the use in the treatment of aneurysms Download PDFInfo
- Publication number
- WO2001021108A1 WO2001021108A1 PCT/US2000/026333 US0026333W WO0121108A1 WO 2001021108 A1 WO2001021108 A1 WO 2001021108A1 US 0026333 W US0026333 W US 0026333W WO 0121108 A1 WO0121108 A1 WO 0121108A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- implant
- vessel
- aneurysmal
- catheter
- intraluminal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2002/065—Y-shaped blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
- A61F2002/077—Stent-grafts having means to fill the space between stent-graft and aneurysm wall, e.g. a sleeve
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0003—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having an inflatable pocket filled with fluid, e.g. liquid or gas
Definitions
- the present invention relates to an implant for the use in the treatment of aneurysmal disease, the implant providing support for an intraluminal graft whilst also enhancing thrombosis in the aneurysmal sac, cellular reaction to and infiltration into the intraluminal graft and fibrosis or similar hardening within the aneurysmal sac.
- grafts are typically introduced into the affected vessel through a distal (or proximal) and connecting vessel to that in which the device is to be used.
- the graft may be inserted in a catheter through the femoral artery.
- any flow of blood to the surrounding aneurysmal sac is prevented. There may, however, still be a substantial volume of blood present in the by-passed aneurysmal sac.
- This blood subsequently undergoes clotting by way of a natural process known as thrombosis.
- the contents of the aneurysmal sac subsequently undergo a further process known as fibrosis, which results in the hardening of the contents.
- the aneurysm starts to shrink and the cells surrounding the intraluminal graft start to adhere and infiltrate the intraluminal graft.
- the overall result is that the intraluminal graft is embedded in the surrounding tissue and thus further secured in place within the vessel.
- the present invention provides an implant adapted to be inserted into a vessel of a patient suffering from aneurysmal disease, the implant being expandable such that when positioned within the vessel it substantially fills the aneurysmal disease, the implant being expandable such that when positioned within the vessel it substantially fills the aneurysmal sac of the vessel and having a surface, the surface being adapted to abut with an intraluminal graft inserted into the vessel.
- the implant includes a tubular wall surrounding an internal passage, the passage being adapted to receive an intraluminal graft inserted therein.
- the present invention provides an intraluminal device adapted to be inserted into a vessel of a patient suffering from aneurysmal disease, the intraluminal device including a tubular graft body having a length and a first and at least second end and an implant disposed around at least a portion of the tubular body wherein when in situ, the implant expands to substantially fill the aneurysmal sac of the vessel in which the device is placed.
- the implant is attached to a portion of the tubular graft body. In a still further embodiment of the second aspect of this invention, the implant is attached to a portion of the tubular graft body.
- the present invention provides a method for positioning an implant in a vessel of a patient suffering from aneurysmal disease, the implant having a tubular wall surrounding an internal passage, the method including the steps of introducing a catheter into the vessel, causing the implant to be moved through the catheter in a compressed state until it extends into the vessel from the proximal end of the catheter wherein when extended from the proximal end of the catheter, the implant moves from its compressed state to an expanded state within the vessel such that the implant expands to substantially fill the aneurysmal sac of the vessel in which it is disposed.
- an intraluminal device is inserted into the vessel such that when in situ, the intraluminal device is positioned internal the implant.
- the walls of the intraluminal device may be inserted into the vessel as a first step and the implant inserted thereafter such that the implant is positioned external the intraluminal device, the implant expanding to fill the aneurysmal sac within which it is disposed.
- the present invention provides a method for positioning an intraluminal device within the vessel of a patient suffering from aneurysmal disease wherein the intraluminal graft body includes a tubular graft body having a length and a first and at least second end and an implant disposed around at least a portion of the wall of the tubular graft body, the method including the steps of introducing a catheter into the body, the method including the steps of introducing a catheter into the vessel, causing the intraluminal device to be moved through the catheter in a vessel, causing the intraluminal device to be moved through the catheter in a compressed state until it extends from the proximal end of the catheter wherein when extended from the proximal end of the catheter, the intraluminal device moves from its compressed state to an expanded state such that the implant expands to substantially fill the aneurysmal sac of the vessel in which the intraluminal device is disposed.
- the material of the implant may be naturally resilient such that it will spring back into shape as soon as a compressive pressure has been removed.
- the implant may be formed from a foam or sponge material.
- the implant is formed of a polymer sponge.
- the implant is formed of a naturally resilient material that has an expansion ratio of from 1.5 : 1 up to 50: 1.
- the implant may be made from a resorbable material such as a resorbable polymer or polycarbonate/polyurethane composite foam or sponge material. It may however be made entirely of a non-resorbable material. It may however be made entirely of non-resorbable material provided that it is bio- compatible and will not set up an inflammatory, or other, reaction in the patient.
- the implant is made from polyurethane alone.
- the implant may be inflatable such that it is inserted in its deflated configuration. Once in situ within the vessel in which it is disposed, fluid may be pumped into the implant such that it takes on its inflated configuration.
- the implant is made from an injectable material such as injectable foam.
- the implant may have particular application in instances where an aneurysm has burst, In this case, the implant can be injected into the aneurysm such that it takes on the shape of the aneurysm before it burst.
- the implant is made from a material adapted to harden when in situ within the vessel. An intraluminal device may be inserted internal the implant and pushed through the hardening material.
- the implant may contain within its structure, metallic wire or wireforms. In the case of non-resorbable tubular member these wires may be a permanent part of the implant.
- these wires may be formed of Nitinol or another material that will change shape at the temperature of blood.
- the wires could be designed to change shape such that when positioned within a vessel of a patient, the implant expands into and substantially fills an aneurysmal sac of a vessel within which it is disposed.
- the material of the implant may be pre-treated with a suitable bioactive, pharmacological or genetically active material to enhance aneurysmal thrombosis, cellular reaction and adhesion to the intraluminal graft fibrosis or hardening within the aneurysmal sac.
- the material of the implant is a biodegradable polymer with thrombogenic properties.
- the implant may be used in the treatment of aortic aneurysms.
- the implant is also suitable for treating aneurysms of the femoral artery, the popliteal artery, the thoracic segment of the aorta, visceral arteries such as the renal and mesenteric arteries, the iliac artery and the sub-clavian artery.
- the implant may be pre-shaped such that it first within an aneurysmal sac of a patient In this manner, an image may be made of the aneurysm (i.e. by ultrasound) and the implant custom to fit securely within the aneurysm.
- the implant is made from a plurality of separate portions. It is envisaged that this embodiment could be used in the case where an aneurysm span the bifurcation of an artery, for example, the aorta-iliac junction. In such a cases, a first portion of the implant could be positioned in the aortic region of the aneurysmal sac and a second portion positioned in the iliac region of the aneurysmal sac, inferior the bifurcation of the aorta.
- the tubular graft body of the intraluminal device is preferably formed of a thin biocompatible material such as DacronTM or polytetrafluoroethylene (PTFE).
- the tuber material is preferably crimped along its length to increase the device's flexibility, however uncrimped material may be used in suitable circumstances.
- tubular graft body of the second and fourth aspects of the invention includes a stent or a series of spaced apart stents which forms a framework to which may be attached an endoluminal graft.
- the framework of the tubular graft body may be circumferentially reinforced along its length by a plurality of separate, spaced-apart, malleable wires.
- Each of such wires can have a generally closed sinusoidal or zigzag shape.
- the wires are preferable formed of stainless steel or another metal of a plastic, which is malleable and is biocompatible.
- Each wire is preferably woven into the fabric of the device body to integrate the body and the reinforcing wires. This prevents any possibility of the wire reinforcement separating from the device body during introduction of the tubular graft body or throughout its life. If the tubular graft body is of a woven material the wires may be interwoven with the tubular graft body after manufacture.
- the wires may be threaded through suitable holes formed in the tubular graft body.
- the stent or stents may be continuous and may be on the radially inner of the radially outer side of the graft wall.
- the tubular graft body is typically substantially of constant diameter along its length, that is, it is substantially cylindrical or may in some instances be frusto-conical in shape with a diameter that increases or decreases along the length of the device.
- the device of aspects two and four of the invention is adapted to bridge the aneurysm that extends up to or slightly beyond an arterial bifurcation.
- the device includes a tubular graft body which has a bifurcation at its downstream end, a so-called :trouser graft", and may be placed wholly within the primary artery.
- a supplemental graft may then be introduced through subsidiary arteries and overlapped with the lumen of the bifurcated part of the primary graft.
- the primary graft In the cases of an aneurysm in the aorta, for instance, that extended into each of the common iliac arteries the primary graft would be placed in the aorta. Supplemental grafts which dock with the bifurcated end of the primary graft would then be inserted through each of the common iliac arteries.
- Figure 1 is a longitudinal section view of an aortic aneurysm within which one embodiment of the present invention has been inserted.
- Figure 2 is a diagrammatic partially cut away ventral view of a patient with an aortic aneurysm which has been bridged by one embodiment of the present invention.
- Figure 3 is a diagrammatic view of an aneurysm located in the region of the bifurcation of the aorta, the aneurysm having been bridged by one embodiment of the present invention.
- An implant of the present invention is generally shown as 10 in the drawings.
- the implant 10 is adapted for insertion transfemorally with an intraluminal graft 11. It is to be understood, however, that the implant 10 may also be inserted independently of the intraluminal graft 11. As is shown in Figure 2, the aorta 12 bifurcates to form the common iliac arteries 13 which subsequently divide into the external 14 and internal 15 iliac arteries, the external iliac artery 14 eventually becoming the femoral artery 16. The aortic aneurysm is located between the renal arteries 17 and the junctions of the bifurcation of the aorta 12 into the common iliac arteries 13.
- the implant 10 is attached to an intraluminal graft 11 along a substantial portion of the length of the intraluminal graft 11. Both the implant and the intraluminal graft are packaged into a catheter (not shown) and introduced into one of the femoral arteries 16. Once the catheter is located approximately which its proximal end in the aorta 12, the implant 10 and intraluminal graft 11 are ejected from the catheter and expanded so that each end 18 and 19 of the intraluminal graft is in intimate contact around its full periphery with the aorta 12 and the implant 10 expands to substantially fill the aneurysmal sac 21.
- the implant 10 comprises three individual segments.
- This embodiment is adapted such that it may be used in respect of an aneurysm spanning the area of the aorta 12 that bifurcates to form the common iliac arteries 13.
- the portions of the implant may be attached to an intraluminal graft 11 of may be inserted into the distinct areas of the aneurysm separately.
Landscapes
- Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU76141/00A AU7614100A (en) | 1999-09-23 | 2000-09-25 | Implants for the use in the treatment of aneurysms |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPQ3028A AUPQ302899A0 (en) | 1999-09-23 | 1999-09-23 | Implants for the use in the treatment of aneurysmal disease |
AUPQ3028 | 1999-09-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001021108A1 true WO2001021108A1 (en) | 2001-03-29 |
Family
ID=3817192
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/026333 WO2001021108A1 (en) | 1999-09-23 | 2000-09-25 | Implants for the use in the treatment of aneurysms |
Country Status (2)
Country | Link |
---|---|
AU (1) | AUPQ302899A0 (en) |
WO (1) | WO2001021108A1 (en) |
Cited By (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003007785A2 (en) * | 2001-07-16 | 2003-01-30 | Microvention, Inc. | Methods, materials and apparatus for deterring or preventing endoleaks following endovascular graft implantation |
EP1397089A1 (en) * | 2001-06-19 | 2004-03-17 | Vortex Innovation Limited | Devices for repairing aneurysms |
EP1465550A1 (en) * | 2001-12-20 | 2004-10-13 | WHITE, Geoffrey H. | A device for use in intraluminal grafting |
WO2004110311A1 (en) * | 2003-06-13 | 2004-12-23 | Universitätsklinikum Freiburg | Suction stent |
US7530988B2 (en) | 2004-07-22 | 2009-05-12 | Nellix, Inc. | Methods and systems for endovascular aneurysm treatment |
WO2009149294A1 (en) | 2008-06-04 | 2009-12-10 | Nellix, Inc. | Sealing apparatus and methods of use |
WO2009158170A1 (en) | 2008-06-04 | 2009-12-30 | Nellix, Inc. | Docking apparatus and methods of use |
US7666220B2 (en) | 2005-07-07 | 2010-02-23 | Nellix, Inc. | System and methods for endovascular aneurysm treatment |
US7790273B2 (en) | 2006-05-24 | 2010-09-07 | Nellix, Inc. | Material for creating multi-layered films and methods for making the same |
US7803395B2 (en) | 2003-05-15 | 2010-09-28 | Biomerix Corporation | Reticulated elastomeric matrices, their manufacture and use in implantable devices |
US7862538B2 (en) | 2008-02-04 | 2011-01-04 | Incept Llc | Surgical delivery system for medical sealant |
WO2011082040A1 (en) | 2009-12-30 | 2011-07-07 | Nellix, Inc. | Filling structure for a graft system and methods of use |
US8044137B2 (en) | 2006-05-30 | 2011-10-25 | Incept Llc | Materials formable in situ within a medical device |
US8048145B2 (en) | 2004-07-22 | 2011-11-01 | Endologix, Inc. | Graft systems having filling structures supported by scaffolds and methods for their use |
US8267989B2 (en) | 2004-01-30 | 2012-09-18 | Trivascular, Inc. | Inflatable porous implants and methods for drug delivery |
WO2014110231A2 (en) | 2013-01-10 | 2014-07-17 | Trivascular, Inc. | Sac liner for aneurysm repair |
US8926682B2 (en) | 2008-04-25 | 2015-01-06 | Nellix, Inc. | Stent graft delivery system |
US8961501B2 (en) | 2010-09-17 | 2015-02-24 | Incept, Llc | Method for applying flowable hydrogels to a cornea |
US8992595B2 (en) | 2012-04-04 | 2015-03-31 | Trivascular, Inc. | Durable stent graft with tapered struts and stable delivery methods and devices |
US9023094B2 (en) | 2007-06-25 | 2015-05-05 | Microvention, Inc. | Self-expanding prosthesis |
US9113999B2 (en) | 2002-09-20 | 2015-08-25 | Nellix, Inc. | Methods for deploying a positioning anchor with a stent-graft |
US9289536B2 (en) | 2013-03-14 | 2016-03-22 | Endologix, Inc. | Method for forming materials in situ within a medical device |
US9393100B2 (en) | 2010-11-17 | 2016-07-19 | Endologix, Inc. | Devices and methods to treat vascular dissections |
US9415195B2 (en) | 2011-04-06 | 2016-08-16 | Engologix, Inc. | Method and system for treating aneurysms |
US9498363B2 (en) | 2012-04-06 | 2016-11-22 | Trivascular, Inc. | Delivery catheter for endovascular device |
US9579103B2 (en) | 2009-05-01 | 2017-02-28 | Endologix, Inc. | Percutaneous method and device to treat dissections |
US9867727B2 (en) | 1998-02-09 | 2018-01-16 | Trivascular, Inc. | Endovascular graft |
WO2018045097A1 (en) * | 2016-08-31 | 2018-03-08 | Endologix, Inc. | Systems and methods with stent and filling structure |
US10159557B2 (en) | 2007-10-04 | 2018-12-25 | Trivascular, Inc. | Modular vascular graft for low profile percutaneous delivery |
CN111195163A (en) * | 2010-12-29 | 2020-05-26 | 爱德华兹生命科学卡迪尔克有限责任公司 | Improved surgical implant devices and methods of making and using the same |
US10772717B2 (en) | 2009-05-01 | 2020-09-15 | Endologix, Inc. | Percutaneous method and device to treat dissections |
CN112203614A (en) * | 2018-05-23 | 2021-01-08 | 帕多瓦大学 | Fenestrated endoprosthesis for correction of aortic aneurysms |
US10888414B2 (en) | 2019-03-20 | 2021-01-12 | inQB8 Medical Technologies, LLC | Aortic dissection implant |
US11298444B2 (en) | 2005-04-01 | 2022-04-12 | Trivascular, Inc. | Non-degradable, low swelling, water soluble radiopaque hydrogel polymer |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997003717A1 (en) * | 1995-07-19 | 1997-02-06 | Endotex Interventional Systems, Inc. | Methods and apparatus for treating aneurysms |
WO1997019653A1 (en) * | 1995-11-27 | 1997-06-05 | Rhodes Valentine J | Endovascular prosthesis with improved sealing means for aneurysmal arterial disease and method of use |
WO1998041167A1 (en) * | 1997-03-14 | 1998-09-24 | Harry Bernard Joseph Spoelstra | Arrangement for the endovascular repair of a blood vessel section |
WO1999023954A1 (en) * | 1997-11-07 | 1999-05-20 | Salviac Limited | Implantable occluder devices for medical use |
-
1999
- 1999-09-23 AU AUPQ3028A patent/AUPQ302899A0/en not_active Abandoned
-
2000
- 2000-09-25 WO PCT/US2000/026333 patent/WO2001021108A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997003717A1 (en) * | 1995-07-19 | 1997-02-06 | Endotex Interventional Systems, Inc. | Methods and apparatus for treating aneurysms |
WO1997019653A1 (en) * | 1995-11-27 | 1997-06-05 | Rhodes Valentine J | Endovascular prosthesis with improved sealing means for aneurysmal arterial disease and method of use |
WO1998041167A1 (en) * | 1997-03-14 | 1998-09-24 | Harry Bernard Joseph Spoelstra | Arrangement for the endovascular repair of a blood vessel section |
WO1999023954A1 (en) * | 1997-11-07 | 1999-05-20 | Salviac Limited | Implantable occluder devices for medical use |
Cited By (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10548750B2 (en) | 1998-02-09 | 2020-02-04 | Trivascular, Inc. | Endovascular graft |
US9867727B2 (en) | 1998-02-09 | 2018-01-16 | Trivascular, Inc. | Endovascular graft |
US8814928B2 (en) | 2001-06-19 | 2014-08-26 | Vortex Innovation Limited | Apparatus and methods for repairing aneurysms |
US10743979B2 (en) | 2001-06-19 | 2020-08-18 | Endologix, Inc. | Apparatus and methods for repairing aneurysms |
EP1397089A1 (en) * | 2001-06-19 | 2004-03-17 | Vortex Innovation Limited | Devices for repairing aneurysms |
EP1397089B1 (en) * | 2001-06-19 | 2017-04-19 | Endologix, Inc. | Devices for repairing aneurysms |
EP2260795A3 (en) * | 2001-06-19 | 2013-04-17 | Novotek Innovation Limited | Devices for repairing aneurysms |
EP1416859A4 (en) * | 2001-07-16 | 2005-11-23 | Microvention Inc | Methods, materials and apparatus for deterring or preventing endoleaks following endovascular graft implantation |
WO2003007785A2 (en) * | 2001-07-16 | 2003-01-30 | Microvention, Inc. | Methods, materials and apparatus for deterring or preventing endoleaks following endovascular graft implantation |
EP1416859A2 (en) * | 2001-07-16 | 2004-05-12 | Microvention, Inc. | Methods, materials and apparatus for deterring or preventing endoleaks following endovascular graft implantation |
WO2003007785A3 (en) * | 2001-07-16 | 2004-02-19 | Microvention Inc | Methods, materials and apparatus for deterring or preventing endoleaks following endovascular graft implantation |
EP1465550A4 (en) * | 2001-12-20 | 2007-05-02 | Geoffrey H White | A device for use in intraluminal grafting |
EP1465550A1 (en) * | 2001-12-20 | 2004-10-13 | WHITE, Geoffrey H. | A device for use in intraluminal grafting |
US9814612B2 (en) | 2002-09-20 | 2017-11-14 | Nellix, Inc. | Stent-graft with positioning anchor |
US9113999B2 (en) | 2002-09-20 | 2015-08-25 | Nellix, Inc. | Methods for deploying a positioning anchor with a stent-graft |
US7803395B2 (en) | 2003-05-15 | 2010-09-28 | Biomerix Corporation | Reticulated elastomeric matrices, their manufacture and use in implantable devices |
US8007541B2 (en) | 2003-06-13 | 2011-08-30 | Mnet Gmbh Medizinische Datensysteme | Suction stent |
US7691153B2 (en) | 2003-06-13 | 2010-04-06 | Universitatskunikum Freiburg | Suction stent |
WO2004110311A1 (en) * | 2003-06-13 | 2004-12-23 | Universitätsklinikum Freiburg | Suction stent |
US8267989B2 (en) | 2004-01-30 | 2012-09-18 | Trivascular, Inc. | Inflatable porous implants and methods for drug delivery |
US10022249B2 (en) | 2004-07-22 | 2018-07-17 | Nellix, Inc. | Graft systems having filling structures supported by scaffolds and methods for their use |
US8048145B2 (en) | 2004-07-22 | 2011-11-01 | Endologix, Inc. | Graft systems having filling structures supported by scaffolds and methods for their use |
US8182525B2 (en) | 2004-07-22 | 2012-05-22 | Endologix, Inc. | Methods and systems for endovascular aneurysm treatment |
US11957608B2 (en) | 2004-07-22 | 2024-04-16 | Nellix, Inc. | Graft systems having filling structures supported by scaffolds and methods for their use |
US10905571B2 (en) | 2004-07-22 | 2021-02-02 | Nellix, Inc. | Graft systems having filling structures supported by scaffolds and methods for their use |
US7530988B2 (en) | 2004-07-22 | 2009-05-12 | Nellix, Inc. | Methods and systems for endovascular aneurysm treatment |
US8870941B2 (en) | 2004-07-22 | 2014-10-28 | Nellix | Graft systems having filling structures supported by scaffolds and methods for their use |
US11298444B2 (en) | 2005-04-01 | 2022-04-12 | Trivascular, Inc. | Non-degradable, low swelling, water soluble radiopaque hydrogel polymer |
US8906084B2 (en) | 2005-07-07 | 2014-12-09 | Nellix, Inc. | System and methods for endovascular aneurysm treatment |
US7666220B2 (en) | 2005-07-07 | 2010-02-23 | Nellix, Inc. | System and methods for endovascular aneurysm treatment |
US9737425B2 (en) | 2005-07-07 | 2017-08-22 | Nellix, Inc. | System and methods for endovascular aneurysm treatment |
US7951448B2 (en) | 2006-05-24 | 2011-05-31 | Nellix, Inc. | Material for creating multi-layered films and methods for making the same |
US7790273B2 (en) | 2006-05-24 | 2010-09-07 | Nellix, Inc. | Material for creating multi-layered films and methods for making the same |
US8044137B2 (en) | 2006-05-30 | 2011-10-25 | Incept Llc | Materials formable in situ within a medical device |
US9023094B2 (en) | 2007-06-25 | 2015-05-05 | Microvention, Inc. | Self-expanding prosthesis |
US10682222B2 (en) | 2007-10-04 | 2020-06-16 | Trivascular, Inc. | Modular vascular graft for low profile percutaneous delivery |
US10159557B2 (en) | 2007-10-04 | 2018-12-25 | Trivascular, Inc. | Modular vascular graft for low profile percutaneous delivery |
US12016766B2 (en) | 2007-10-04 | 2024-06-25 | Trivascular, Inc. | Modular vascular graft for low profile percutaneous delivery |
US7862538B2 (en) | 2008-02-04 | 2011-01-04 | Incept Llc | Surgical delivery system for medical sealant |
US9730700B2 (en) | 2008-04-25 | 2017-08-15 | Nellix, Inc. | Stent graft delivery system |
US10898201B2 (en) | 2008-04-25 | 2021-01-26 | Nellix, Inc. | Stent graft delivery system |
US8926682B2 (en) | 2008-04-25 | 2015-01-06 | Nellix, Inc. | Stent graft delivery system |
US8945199B2 (en) | 2008-06-04 | 2015-02-03 | Nellix, Inc. | Sealing apparatus and methods of use |
WO2009149294A1 (en) | 2008-06-04 | 2009-12-10 | Nellix, Inc. | Sealing apparatus and methods of use |
WO2009158170A1 (en) | 2008-06-04 | 2009-12-30 | Nellix, Inc. | Docking apparatus and methods of use |
US9579103B2 (en) | 2009-05-01 | 2017-02-28 | Endologix, Inc. | Percutaneous method and device to treat dissections |
US10772717B2 (en) | 2009-05-01 | 2020-09-15 | Endologix, Inc. | Percutaneous method and device to treat dissections |
US11638638B2 (en) | 2009-12-30 | 2023-05-02 | Endologix Llc | Filling structure for a graft system and methods of use |
WO2011082040A1 (en) | 2009-12-30 | 2011-07-07 | Nellix, Inc. | Filling structure for a graft system and methods of use |
US8961501B2 (en) | 2010-09-17 | 2015-02-24 | Incept, Llc | Method for applying flowable hydrogels to a cornea |
US9393100B2 (en) | 2010-11-17 | 2016-07-19 | Endologix, Inc. | Devices and methods to treat vascular dissections |
CN111195163B (en) * | 2010-12-29 | 2022-04-01 | 爱德华兹生命科学卡迪尔克有限责任公司 | Improved surgical implant devices and methods of making and using the same |
CN111195163A (en) * | 2010-12-29 | 2020-05-26 | 爱德华兹生命科学卡迪尔克有限责任公司 | Improved surgical implant devices and methods of making and using the same |
US10390836B2 (en) | 2011-04-06 | 2019-08-27 | Endologix, Inc. | Method and system for treating aneurysms |
US9415195B2 (en) | 2011-04-06 | 2016-08-16 | Engologix, Inc. | Method and system for treating aneurysms |
US11786252B2 (en) | 2011-04-06 | 2023-10-17 | Endologix Llc | Method and system for treating aneurysms |
US10349946B2 (en) | 2011-04-06 | 2019-07-16 | Endologix, Inc. | Method and system for treating aneurysms |
US8992595B2 (en) | 2012-04-04 | 2015-03-31 | Trivascular, Inc. | Durable stent graft with tapered struts and stable delivery methods and devices |
US9498363B2 (en) | 2012-04-06 | 2016-11-22 | Trivascular, Inc. | Delivery catheter for endovascular device |
WO2014110231A2 (en) | 2013-01-10 | 2014-07-17 | Trivascular, Inc. | Sac liner for aneurysm repair |
US9289536B2 (en) | 2013-03-14 | 2016-03-22 | Endologix, Inc. | Method for forming materials in situ within a medical device |
US11013591B2 (en) | 2016-08-31 | 2021-05-25 | Endologix Llc | Systems and methods with stent and filling structure |
WO2018045097A1 (en) * | 2016-08-31 | 2018-03-08 | Endologix, Inc. | Systems and methods with stent and filling structure |
JP7408391B2 (en) | 2016-08-31 | 2024-01-05 | エンドーロジックス リミテッド ライアビリティ カンパニー | Systems and methods with stents and filling structures |
JP2019529008A (en) * | 2016-08-31 | 2019-10-17 | エンドーロジックス インコーポレイテッド | Systems and methods having stents and filling structures |
CN112203614A (en) * | 2018-05-23 | 2021-01-08 | 帕多瓦大学 | Fenestrated endoprosthesis for correction of aortic aneurysms |
US10888414B2 (en) | 2019-03-20 | 2021-01-12 | inQB8 Medical Technologies, LLC | Aortic dissection implant |
Also Published As
Publication number | Publication date |
---|---|
AUPQ302899A0 (en) | 1999-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001021108A1 (en) | Implants for the use in the treatment of aneurysms | |
EP0857040B1 (en) | Tubular prosthesis comprising an in-situ expanding conformable sealing layer | |
EP0883384B1 (en) | Expandable supportive branched endoluminal grafts | |
US9408688B2 (en) | Devices and methods for treatment of abdominal aortic aneurysm | |
US6361556B1 (en) | System and method for endovascular aneurysm repair in conjuction with vascular stabilization | |
EP1874231B1 (en) | Graft systems having filling structures supported by scaffolds | |
US20040098096A1 (en) | Endograft device to inhibit endoleak and migration | |
US20150105848A1 (en) | Graft systems having filling structures supported by scaffolds and methods for their use | |
US20020123790A1 (en) | Enhanced engagement member for anchoring prosthetic devices in body lumen | |
EP1067883A1 (en) | An implant comprising a support structure and a transition material made of porous plastics material | |
US7556643B2 (en) | Graft inside stent | |
EP1214017B1 (en) | Double layer intraluminal graft | |
AU767566B2 (en) | Expanding intraluminal device | |
AU778349B2 (en) | Pre-shaped intraluminal graft | |
CN113038909A (en) | Stent graft system and method with inflatable filling structure and fillable cuff | |
AU2004200295B2 (en) | Expanding intraluminal device | |
AU5740000A (en) | Double layer intraluminal graft |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |